VIOXX Lawsuits

Vioxx is a prescription medication that has been used primarily in the treatment of signs and symptoms of arthritis, but has also been prescribed to treat acute pain in adults and menstrual pain in women. It is a Cox-2 selective nonsteroidal anti-inflammatory drug or NSAID. Other Cox -2 selective NSAIDs on the market are Celebrex and Bextra. Vioxx is also related to nonselective NSAIDs such as ibuprofen and naproxen.

In September of 2004, its manufacturer, Merck & Co, voluntarily recalled Vioxx worldwide, due to safety concerns. The FDA issued a public advisory regarding the safety of Vioxx, though it was pulled from the market before the FDA had an opportunity to do a thorough review.

During a clinical trial in which Vioxx was being studied for its effectiveness for preventing the recurrence of colon polyps and as well as its long term safety, the study had to be halted because of the observed risk of increased cardiovascular risk after 18 months of continuous treatment with 25mg of Vioxx as opposed to those receiving a placebo (sugar pill). Merck pulled the drug from the market when the study confirmed longstanding concerns about the drug and demonstrated that the regular use of Vioxx doubled the patient's risk of heart attack or stroke if used regularly and for a prolonged period.

The FDA originally approved Vioxx in May 1999. At that time, their data, which included approximately 5,000 patients, did not indicate an increased risk for heart attack and strokes. However, later studies such as the one involving colon polyps, and another to study the effects of Vioxx upon stomach ulcers, show a correlation between the regular use of Vioxx and increased risk for heart attack or stroke.

After the recall of Vioxx, many doctors have recommended patients switch to other Cox-2 inhibitors such as Celebrex or Bextra, however, these medications have raised health concerns as well. Other patients have been advised to treat their symptoms with NSAIDs such as ibuprofen or naproxen.

Vioxx Help Center

The Vioxx MDL # is 1657: Section L. Correspondence with Judge Eldon E. Fallon may be sent to the following address:

Honorable Eldon E. Fallon
United States District Court,
Eastern District of Louisiana
500 Poydras Street, Room C-456
New Orleans, LA 70130
Tel:(504) 589-7545
Fax: (504) 589-6966
Web Site: Vioxx Product Liability

Wayne Walker is president of CapTran, the leader in litigation financial services. http://www.captran.com

© 2005 Capital Transaction Group Inc

Latest News


BioImagene CEO, Dr. Ajit Singh, Speaks On Enabling Personalized ...
MarketWatch - 59 minutes ago
Digital pathology, a key enabler for personalized medicine, will aid clinicians in managing and interpreting data from a whole new set of diagnostic tests ...
Aperio Introduces SecondSlide(TM) Digital Slide Sharing Network MarketWatch
all 15 news articles

eFluxMedia

Medicine for the Job Market
New York Times, United States - 10 hours ago
By JONATHAN GRUBER A CENTRAL feature of Barack Obama’s presidential campaign was an aggressive plan to expand health insurance coverage by subsidizing ...
Reform or bust Barre Montpelier Times Argus
New Report Shows Slower Premium Growth, But Increasing Pressure to ... MarketWatch
Health Corps Harvard International Review
Huffington Post - The Plain Dealer - cleveland.com
all 205 news articles

eFluxMedia

American College of Surgeons Comments on Institute of Medicine ...
MarketWatch - 18 hours ago
CHICAGO, Dec 03, 2008 /PRNewswire-USNewswire via COMTEX/ -- The American College of Surgeons (ACS) today recognized the Institute of Medicine (IOM) for its ...
Report urges more sleep for medical residents Los Angeles Times
Medical Residents Must Sleep After 16 Hours, Experts Urge Washington Post
Expert Panel Seeks Changes in Training of Medical Residents New York Times
Peoria Journal Star - findingDulcinea
all 326 news articles

Research and Markets: 2008 Integrative Medicine and Dietary ...
MarketWatch - 59 minutes ago
In this 32-page issue, we offer a breakdown of 2007 US Complementary and Alternative Medicine sales data and provides a detailed analysis of new integrative ...

Afrik.com

34 Nigerian Children Dead From Tainted Medicine
Voice of America - 23 hours ago
By VOA News Nigerian health officials say they are flying in doses of an antidote for a poisoned teething medicine that has now killed 34 infants. ...
'Toxic' syrup kills Nigerian babies Aljazeera.net
Teething mixture kills more Nigerian babies Monsters and Critics.com
Nigeria infant drug toll hits 34, antidote flown in Reuters South Africa
The Associated Press - NgEX
all 113 news articles

Research database from the US Library of Medicine
The Plain Dealer - cleveland.com, OH - 2 hours ago
Search PubMed, Clinicaltrials.gov, the CDC and a dozen other medical sites - all at once. AP MEDICAL VIDEO by Michael O'Malley and Joan Mazzolini/Plain ...

A New Index of Preventive Medicine Companies
Motley Fool - 15 hours ago
The accompanying table [click to enlarge] presents statistics and the top 15 rated companies in the ETF Innovators [ETFI] Preventive Medicine Index. ...

NIGERIA: Jos displaced grapple with food, water, medicine shortages
IRINnews.org, NY - 1 hour ago
JOS, 4 December 2008 (IRIN) - Water, medicine and food supplies are running low for an estimated 10000 people displaced by violence in Jos, northern Nigeria ...

Canada.com

"Rogue" stem cell clinics exploit hope: report
Reuters - 13 hours ago
"The direct-to-consumer portrayal of stem cell medicine is optimistic and unsupported by published evidence," Timothy Caulfield of the University of Alberta ...
Scientists warn of “rogue” online stem cell clinics p2pnet.net
Internet stem-cell clinics 'exploiting' MS and Parkinson's patients Times Online
The International Society for Stem Cell Research Releases New ... MarketWatch
MIT Technology Review - MarketWatch
all 391 news articles

TheMedGuru

Extended Drug Therapy for Hepatitis Is Challenged
New York Times, United States - 5 hours ago
“This is a treatment that should not be done,” said Dr. Howard Worman, professor of medicine at Columbia University College of Physicians and Surgeons, ...
Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose ... New England Journal of Medicine (subscription)
Treatment for advanced hepatitis C doesn't work, researchers find EurekAlert (press release)
Hepatitis C Therapy Useless for Some Washington Post
WELT ONLINE - MedPage Today
all 55 news articles

Resources


    Sorry Currently Unavailable